1 |
Keto J, Kaartinen T, Salmenniemi U, et al. Immunomonitoring of MSC-Treated GvHD patients reveals only moderate potential for response prediction but indicates treatment safety[J]. Mol Ther Methods Clin Dev, 2018, 9:109-118.
|
2 |
Wang XL, Zhao YY, Sun L, et al. Exosomes derived from human umbilical cord mesenchymal stem cells improve myocardial repair via upregulation of Smad7[J]. Int J Mol Med, 2018, 41(5):3063-3072.
|
3 |
张玲,张祥忠,李晓青, 等. 脐带间充质干细胞治疗难治性慢性移植物抗宿主病的疗效观察[J]. 器官移植, 2016, 7(6):459-462.
|
4 |
Zhao K, Lou R, Huang F, et al. Immunomodulation effects of mesenchymal stromal cells on acute graft-versus-host disease after hematopoietic stem cell transplantation[J]. Biol Blood Marrow Transplant, 2015, 21(1):97-104.
|
5 |
Muller I, Kordowich S, Holzwarth C, et al. Application of multipotent mesenchymal stromal cells in pediatric patients following allogeneic stem cell transplantation[J]. Blood Cells Mol Dis, 2008, 40(1):25-32.
|
6 |
Liu T, Zhang Y, Shen Z, et al. Immunomodulatory effects of OX40Ig gene-modified adipose tissue-derived mesenchymal stem cells on rat kidney transplantation[J]. Int J Mol Med, 2017, 39(1):144-152.
|
7 |
Jin X, Su R, Li R, et al. Crucial role of pro-inflammatory cytokines from respiratory tract upon PM2.5 exposure in causing the BMSCs differentiation in cells and animals[J]. Oncotarget, 2018, 9(2):1745-1759.
|
8 |
Fang Y, Chu L, Li L, et al. Tetramethylpyrazine protects bone marrow-derived mesenchymal stem cells against hydrogen peroxide-induced apoptosis through PI3K/Akt and ERK1/2 pathways[J]. Biol Pharm Bull, 2017, 40(12):2146-2152.
|
9 |
Huang H, He J, Teng X, et al. Combined intrathymic and intravenous injection of mesenchymal stem cells can prolong the survival of rat cardiac allograft associated with decrease in miR-155 expression[J]. J Surg Res, 2013, 185(2):896-903.
|
10 |
Zhang A, Wang K, Zhou C, et al. Knockout of microRNA-155 ameliorates the Th1/Th17 immune response and tissue injury in chronic rejection[J]. J Heart Lung Transplant, 2017, 36(2):175-184.
|
11 |
Aboelenein HR, Hamza MT, Marzouk H, et al. Reduction of CD19 autoimmunity marker on B cells of paediatric SLE patients through repressing PU.1/TNF-alpha/BAFF axis pathway by miR-155[J]. Growth Factors, 2017, 35(2-3):49-60.
|
12 |
Elmesmari A, Fraser AR, Wood C, et al. MicroRNA-155 regulates monocyte chemokine and chemokine receptor expression in Rheumatoid Arthritis[J]. Rheumatology (Oxford), 2016, 55(11):2056-2065.
|
13 |
Garcia-Rodriguez S, Arias-Santiago S, Blasco-Morente G, et al. Increased expression of microRNA-155 in peripheral blood mononuclear cells from psoriasis patients is related to disease activity[J]. J Eur Acad Dermatol Venereol, 2017, 31(2):312-322.
|
14 |
Yan L, Hu F, Yan X, et al. Inhibition of microRNA-155 ameliorates experimental autoimmune myocarditis by modulating Th17/Treg immune response[J]. J Mol Med (Berl), 2016, 94(9):1063-1079.
|
15 |
Iberg CA, Jones A, Hawiger D. Dendritic cells as inducers of peripheral tolerance[J]. Trends Immunol, 2017, 38(11):793-804.
|
16 |
Huang C, Zhang L, Ling F, et al. Effect of immune tolerance induced by immature dendritic cells and CTLA4-Ig on systemic lupus erythematosus: An in vivo study[J]. Exp Ther Med, 2018, 15(3):2499-2506.
|
17 |
Wan J, Huang F, Hao S, et al. Interleukin-10 gene-modified dendritic cell-induced type 1 regulatory T cells induce transplant-tolerance and impede graft versus host disease after allogeneic stem cell transplantation[J]. Cell Physiol Biochem, 2017, 43(1):353-366.
|
18 |
Lee YS, Sah SK, Lee JH, et al. Human umbilical cord blood-derived mesenchymal stem cells ameliorate psoriasis-like skin inflammation in mice[J]. Biochem Biophys Rep, 2017, 9:281-288.
|
19 |
Sadeghi L, Karimi MH, Kamali-Sarvestani E, et al. The immunomodulatory effect of bone-marrow mesenchymal stem cells on expression of TLR3 and TLR9 in mice dendritic cells[J]. Int J Organ Transplant Med, 2017, 8(1): 5-42.
|
20 |
Tsukamoto H, Fujieda K, Hirayama M, et al. Soluble IL6R expressed by myeloid cells reduces tumor-specific Th1 differentiation and drives tumor progression[J]. Cancer Res, 2017, 77(9):2279-2291.
|
21 |
Pichler R, Gruenbacher G, Culig Z, et al. Intratumoral Th2 predisposition combines with an increased Th1 functional phenotype in clinical response to intravesical BCG in bladder cancer[J]. Cancer Immunol Immunother, 2017, 66(4):427-440.
|
22 |
Dewitte H, Verbeke R, Breckpot K, et al. Choose your models wisely: how different murine bone marrow-derived dendritic cell protocols influence the success of nanoparticulate vaccines in vitro[J]. J Control Release, 2014, 195:138-146.
|
23 |
Salmenniemi U, Itala-Remes M, Nystedt J, et al. Good responses but high TRM in adult patients after MSC therapy for GvHD[J]. Bone Marrow Transplant, 2017, 52(4):606-608.
|
24 |
Sun Y, Kong W, Huang S, et al. Comparable therapeutic potential of umbilical cord mesenchymal stem cells in collagen-induced arthritis to TNF inhibitor or anti-CD20 treatment[J]. Clin Exp Rheumatol, 2017, 35(2):288-295.
|
25 |
Yu Y, Liao L, Shao B, et al. Knockdown of MicroRNA Let-7a improves the functionality of bone marrow-derived mesenchymal stem cells in immunotherapy[J]. Mol Ther, 2017, 25(2):480-493.
|
26 |
Wu M, Guo X, Yang L, et al. Mesenchymal stem cells with modification of junctional adhesion molecule a induce hair formation[J]. Stem Cells Transl Med, 2014, 3(4):481-488.
|
27 |
Li Y, Duo Y, Bi J, et al. Targeted delivery of anti-miR-155 by functionalized mesoporous silica nanoparticles for colorectal cancer therapy[J]. Int J Nanomedicine, 2018, 13:1241-1256.
|
28 |
Tu YX, Wang SB, Fu LQ, et al. Ovatodiolide targets chronic myeloid leukemia stem cells by epigenetically upregulating hsa-miR-155, suppressing the BCR-ABL fusion gene and dysregulating the PI3K/AKT/mTOR pathway[J]. Oncotarget, 2018, 9(3):3267-3277.
|
29 |
Peng J, Liu H, Liu C. MiR-155 promotes uveal melanoma cell proliferation and invasion by regulating NDFIP1 expression[J]. Technol Cancer Res Treat, 2017, 16(6):1160-1167.
|